Menu

Bioluminux Clinical Research - Illinois

Naperville, Illinois United States

Claim This Site

Are you the site administrator? Claim this site to update information.

5Total Trials
3Recruiting Trials
4Active Trials
1Completed Trials
16Unique Conditions
4Unique Sponsors

Conditions

Acute Gout Flare (1)Acute Gouty Arthritis (1)Body Weight (1)Gout Flare (1)Gout Flares (1)Immunoglobulin A Nephropathy (1)Nutritional and Metabolic Diseases (1)Nutrition Disorders (1)

Sponsors

Pfizer (2)Alpine Immune Sciences Inc, A Subsidiary of Vertex (1)Altesa Biosciences, Inc. (1)Atom Therapeutics Co., Ltd (1)

Basic Information

Site Overview

Bioluminux Clinical Research Illinois is a clinical research site located in Naperville, Illinois, serving as the global headquarters of BioLuminux Clinical Research. The organization conducts Phase II–IV clinical trials across multiple therapeutic areas, including metabolic disorders, central nervous system (CNS) conditions, dermatology, vaccines, and infectious diseases. It collaborates with pharmaceutical companies, biotechnology firms, and contract research organizations (CROs) to support the development of innovative therapies and medical treatments. The Illinois site is equipped with modern clinical research infrastructure, including consultation rooms, laboratories, investigational product storage, monitoring facilities, and GCP-compliant data management systems. The organization is recognized for its patient-centered approach, strong regulatory compliance, and commitment to ethical clinical research practices. Bioluminux also emphasizes diversity in clinical trial…

Accessibility & Parking

Accessibility Features

Wheelchair accessible entrance
Wheelchair accessible parking lot